Zacks Investment Research on MSN
Natera to launch enhanced Panorama NIPT for low fetal fractions
Natera NTRA recently announced a major upgrade to its Panorama non-invasive prenatal test (NIPT). Powered by the company’s ...
4d
Natera to Launch Enhanced Panorama™ NIPT, Powered by Novel SNP-Informed Deep Sequencing Technology
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing and precision medicine, today announced a major ...
AUSTIN, Texas--(BUSINESS WIRE)-- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing and precision medicine, today announced the launch of Fetal Focus, a noninvasive prenatal ...
Natera has recently reported a string of developments, from launching the SIGNAL-ER 101 trial using Signatera for MRD-guided de-escalation in early-stage breast cancer, to collaborating with Diakonos ...
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) and Natera, Inc. today announced they have entered into a three-year agreement whereby Illumina will supply Natera with the HiSeq® 2500 ...
SAN CARLOS, Calif. & DALLAS--(BUSINESS WIRE)--Natera, a leading innovator in prenatal genetic testing, today announced the initiation of a distribution partnership with ProPath, a wholly ...
SAN CARLOS, Calif., March 5, 2018 /PRNewswire/ -- Natera, Inc., (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today announced that Yale New ...
EXPAND is a prospective, blinded, multi-site clinical trial with diagnostic outcomes on all subjects AUSTIN, Texas--(BUSINESS WIRE)-- Natera, Inc. (NTRA), a global leader in cell-free DNA (cfDNA) ...
Natera to introduces enhanced Panorama NIPT, powered by novel SNP-informed deep sequencing technology: Austin, Texas Wednesday, May 27, 2026, 16:00 Hrs [IST] Natera, Inc., a globa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results